NIST Awards Over $1.2 Million to Small Businesses to Advance Cybersecurity, Biopharmaceuticals, Semiconductors and More

NIST Awards Over $1.2 Million to Small Businesses to Advance Cybersecurity, Biopharmaceuticals, Semiconductors and More

Credit: Shutterstock


GAITHERSBURG, Md. — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded more than $1.2 million to 12 small businesses in eight states under the Small Business Innovation Research (SBIR) Program. The awards will fund research and development of new products relating to cybersecurity, quantum computing, health care, semiconductor manufacturing and other critical areas.


The award-winning projects were competitively selected from proposals submitted in response to a call for innovative projects that address technical needs related to NIST’s research areas.


These are all Phase I SBIR awards, which are meant to establish the merit, feasibility and commercial potential of the proposed research and development projects. After completing their Phase I projects, awardees are eligible to apply for Phase II funding of up to $400,000 to continue their efforts. 


2024 Phase I SBIR Awardees


AMAG Consulting LLC (Schenectady, New York) — $100,000Advanced SEM simulation software for the semiconductor industry — a graphical user interface for software that simulates the interaction of electron beams with solid materials in scanning electron microscopy and that will help solve critical problems in the measurement of very small components in semiconductors and other devices.


Applied Imaging Solutions LLC (Quincy, Massachusetts) — $99,759Hyperspectral imaging with AI/deep learning for online monitoring of NISTCHO viability and cell culture metabolites in real-time — to advance the safe and efficient adoption of contactless AI/deep learning sensing systems for fine control of bioreactor environments, which is an important need in the fast-growing biopharmaceutical industry.


Calimetrix LLC (Madison, Wisconsin) — $105,284Multimodality quantitative phantom for magnetic resonance imaging and computed tomography measurements of steatotic liver disease — to develop an imaging test object, or “phantom,” of the human liver, to pro ..

Support the originator by clicking the read the rest link below.